John Borshoff – Managing Director – Deep Yellow (ASX:DYL) is successfully progressing a dual-pillar growth strategy to establish a globally diversified, Tier-1 uranium company to produce 10+ Mlb pa.
Copyright 2024 – Finance News Network
Source: Finance News Network
01 Dec 2021 - MinRex Resources Limited (ASX:MRR) Non-Executive Director George Karageorge provides an update on the company's gold and base metals projects in WA and the Lachlan Ford Belt, NSW and its recently acquired lithium projects in the Pilbara.
Read More31 Oct 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market outlook, giving general advice on investment implications.
Read More27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
Read More15 Feb 2022 - Imdex (ASX:IMD) CEO Paul House discusses drivers behind the company's 1H22 performance, research and development, and outlook.
Read More30 May 2022 - Fred Pye, CEO and Chairman of digital asset manager 3iQ, discusses the future of cryptocurrencies and the launch of two crypto ETFs in Australia based on Ethereum and Bitcoin.
Read More25 May 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the paradox of rising valuations in a looming bear market.
Read More08 Dec 2021 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the cracking of the "silicon barrier" in order to significantly increase the energy retention and capacity of lithium-ion batteries for electric vehicles.
Read More20 Mar 2024 - Dotz Nano Limited (ASX:DTZ) CEO Sharon Malka discusses development of Dotz Earth, a new-generation sorbent technology for carbon dioxide capture.
Read More01 Apr 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari introduces the company, discussing the use of radiopharmaceuticals for cancer treatment and the company's upcoming trial in non-small cell lung cancer.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More
